Kyoto, Japan

Keiichiro Fukushima

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiichiro Fukushima. Retrieved from https://idiyas.com/inventor/keiichiro-fukushima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiichiro Fukushima: Innovator in Medicinal Chemistry

Introduction

Keiichiro Fukushima is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions that address pressing health issues.

Latest Patents

Fukushima holds a patent for a heteroaromatic amide derivative and a medicament containing the same. This compound demonstrates high efficacy for diseases associated with Nav1.7, which is crucial for pain signaling in the nervous system. The patent is represented by the general formula (I), showcasing his expertise in creating effective medicinal compounds.

Career Highlights

Fukushima is affiliated with Kaken Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work has contributed to the company's reputation for innovation in drug development.

Collaborations

Throughout his career, Fukushima has collaborated with talented individuals such as Ryota Kotaka and Sadayoshi Furuta. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Keiichiro Fukushima is a distinguished inventor whose work in medicinal chemistry has led to significant advancements in the treatment of diseases. His innovative approach and dedication to research continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…